or
forgot password

    • cancer clinical trials in lansing, MI

    • EGb761 in Maintaining Mental Clarity in Women Receiving Chemotherapy for Newly Diagnosed Breast Cancer
    Sparrow Regional Cancer Center
    Lansing, Michigan 48912-1811
    Breast Cancer, Neurotoxicity
    Neoadjuvant Chemotherapy With or Without Second-Look Surgery Followed by Radiation Therapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Intracranial Germ Cell Tumors
    Breslin Cancer Center at Ingham Regional Medical Center
    Lansing, Michigan 48910
    Brain and Central Nervous System Tumors, Childhood Germ Cell Tumor
    TLK286 (Telcyta) vs. Doxil/Caelyx or Hycamtin in Platinum Refractory or Resistant Ovarian Cancer
    Sparrow Regional Cancer Center
    Lansing, Michigan 48912-1811
    Ovarian Neoplasms
    Epoetin Alfa With or Without Dexamethasone in Treating Fatigue and Anemia in Patients With Hormone-Refractory Prostate Cancer
    Sparrow Regional Cancer Center
    Lansing, Michigan 48912-1811
    Anemia, Fatigue, Prostate Cancer
    Cisplatin, Etoposide, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
    Sparrow Regional Cancer Center
    Lansing, Michigan 48912-1811
    Lung Cancer
    Inhaled Sargramostim in Treating Patients With First Pulmonary (Lung) Recurrence of Osteosarcoma
    Breslin Cancer Center at Ingham Regional Medical Center
    Lansing, Michigan 48910
    Metastatic Cancer, Sarcoma
    Combination Chemotherapy in Treating Children With Newly Diagnosed Malignant Germ Cell Tumors
    Breslin Cancer Center at Ingham Regional Medical Center
    Lansing, Michigan 48910
    Childhood Germ Cell Tumor, Extragonadal Germ Cell Tumor
    Doxorubicin and Gemcitabine in Treating Patients With Locally Recurrent or Metastatic Unresectable Renal Cell Carcinoma
    Sparrow Regional Cancer Center
    Lansing, Michigan 48912-1811
    Metastatic Renal Cell Carcinoma, Renal Cell Carcinoma With Sarcomatoid Features
    Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Locally Advanced Cancer of the Vulva
    Sparrow Regional Cancer Center
    Lansing, Michigan 48912-1811
    Vulvar Cancer
    Gemcitabine and Vinorelbine in Treating Young Patients With Recurrent or Refractory Hodgkin's Lymphoma
    Breslin Cancer Center at Ingham Regional Medical Center
    Lansing, Michigan 48910
    Lymphoma
    Octreotide in Preventing or Reducing Diarrhea in Patients Receiving Chemoradiotherapy for Anal or Rectal Cancer
    Sparrow Regional Cancer Center
    Lansing, Michigan 48912-1811
    Anal Cancer, Colorectal Cancer, Drug/Agent Toxicity by Tissue/Organ, Radiation Enteritis
    Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer
    Sparrow Regional Cancer Center
    Lansing, Michigan 48912-1811
    Breast Cancer
    Study of TLK286 (Telcyta) vs. Gefitinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer
    Sparrow Health System
    Lansing, Michigan 48912
    Non Small Cell Lung Carcinoma
    hu14.18-Interleukin-2 Fusion Protein in Treating Young Patients With Recurrent or Refractory Neuroblastoma
    Breslin Cancer Center at Ingham Regional Medical Center
    Lansing, Michigan 48910
    Neuroblastoma
    Levocarnitine in Treating Fatigue in Cancer Patients
    Sparrow Regional Cancer Center
    Lansing, Michigan 48912-1811
    Fatigue, Unspecified Adult Solid Tumor, Protocol Specific
    Tetracycline in Preventing Skin Rash in Patients Who Are Receiving Drugs Such as Gefitinib and Cetuximab for Cancer
    Sparrow Regional Cancer Center
    Lansing, Michigan 48912-1811
    Unspecified Adult Solid Tumor, Protocol Specific
    Capecitabine, Vinorelbine, and Trastuzumab in Treating Patients With Metastatic Breast Cancer
    Sparrow Regional Cancer Center
    Lansing, Michigan 48912-1811
    Breast Cancer
    Amifostine in Treating Young Patients With Newly Diagnosed De Novo Myelodysplastic Syndromes
    Breslin Cancer Center at Ingham Regional Medical Center
    Lansing, Michigan 48910
    Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
    Radiation Therapy, Temozolomide, and Lomustine in Treating Young Patients With Newly Diagnosed Gliomas
    Breslin Cancer Center at Ingham Regional Medical Center
    Lansing, Michigan 48910
    Brain and Central Nervous System Tumors
    Pemetrexed Plus Gemcitabine or Carboplatin for Patients With Advanced Malignant Pleural Mesothelioma
    Sparrow Regional Cancer Center
    Lansing, Michigan 48912-1811
    Mesothelioma
    Alternative Dosing Regimens of Subcutaneous Azacitidine for Myelodysplastic Syndromes
    Great Lakes Cancer Institute Breslin Cancer Center
    Lansing, Michigan 48910
    Myelodysplastic Syndromes
    Cetuximab in Treating Patients With Recurrent or Stage IIIB or Stage IV Lung Cancer
    Sparrow Regional Cancer Center
    Lansing, Michigan 48912-1811
    Lung Cancer
    S0430 Cyclophosphamide and Capecitabine in Treating Women With Stage IV Breast Cancer
    Breslin Cancer Center at Ingham Regional Medical Center
    Lansing, Michigan 48910
    Breast Cancer
    Bevacizumab, Gemcitabine, and Oxaliplatin in Treating Patients With Metastatic Pancreatic Cancer
    Sparrow Regional Cancer Center
    Lansing, Michigan 48912-1811
    Pancreatic Cancer
    Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer That Cannot Be Removed By Surgery
    Breslin Cancer Center at Ingham Regional Medical Center
    Lansing, Michigan 48910
    Head and Neck Cancer
    Topotecan in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer
    Sparrow Regional Cancer Center
    Lansing, Michigan 48912-1811
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Bevacizumab and Combination Chemotherapy in Patients With Lymph Node Positive Breast Cancer
    Sparrow Regional Cancer Center
    Lansing, Michigan 48912-1811
    Breast Cancer
    S0515 Combination Chemo, Rituximab, and Bevacizumab in Older Patients With Stage II-IV Diffuse Large B-Cell Lymphoma
    Breslin Cancer Center at Ingham Regional Medical Center
    Lansing, Michigan 48910
    Lymphoma
    S0417 Bortezomib, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
    Sparrow Regional Cancer Center
    Lansing, Michigan 48912-1811
    Multiple Myeloma
    Cetuximab and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer
    Sparrow Regional Cancer Center
    Lansing, Michigan 48912-1811
    Lung Cancer
    Pemetrexed Disodium and Carboplatin in Treating Patients With Extensive-Stage Small Cell Lung Cancer
    Sparrow Regional Cancer Center
    Lansing, Michigan 48912-1811
    Lung Cancer
    S0509: AZD2171 in Treating Patients With Malignant Pleural Mesothelioma That Cannot Be Removed By Surgery
    Sparrow Regional Cancer Center
    Lansing, Michigan 48912-1811
    Malignant Mesothelioma
    S0526: Pemetrexed Disodium in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
    Sparrow Regional Cancer Center
    Lansing, Michigan 48912-1811
    Lung Cancer
    Pyridoxine and Topical Urea/Lactic Acid-Based Cream in Preventing Hand-Foot Syndrome in Patients Receiving Capecitabine for Breast Cancer or Other Cancer
    Sparrow Regional Cancer Center
    Lansing, Michigan 48912-1811
    Breast Cancer, Drug/Agent Toxicity by Tissue/Organ, Unspecified Adult Solid Tumor, Protocol Specific
    Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma
    Sparrow Regional Cancer Center
    Lansing, Michigan 48912-1811
    Brain and Central Nervous System Tumors
    Motexafin Gadolinium, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma
    Sparrow Hospital
    Lansing, Michigan 48912
    Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma
    Irinotecan and Temozolomide in Treating Young Patients With Recurrent Neuroblastoma
    Breslin Cancer Center at Ingham Regional Medical Center
    Lansing, Michigan 48910
    Neuroblastoma
    Safety and Efficacy Study of Alfimeprase in Subjects With Occluded Catheters
    Sparrow Cancer Center
    Lansing, Michigan 48912
    Thrombosis, Venous Thrombosis, Catheter Occlusion
    Safety and Tolerability Study of FolateImmune in Combination With Cytokines in Patients With Refractory or Metastatic Cancer
    Great Lakes Cancer Institute Breslin Cancer Center
    Lansing, Michigan 48910
    Cancer
    S0618 E7389 in Treating Patients With Metastatic or Recurrent Head and Neck Cancer
    Sparrow Regional Cancer Center
    Lansing, Michigan 48912-1811
    Head and Neck Cancer
    Pilocarpine in Treating Vaginal Dryness in Patients With Breast Cancer
    Sparrow Regional Cancer Center
    Lansing, Michigan 48912-1811
    Breast Cancer, Sexual Dysfunction, Sexuality and Reproductive Issues
    Topical Sunscreen in Preventing Skin Rash in Patients Receiving Drugs Such as Erlotinib or Cetuximab for Cancer
    Sparrow Regional Cancer Center
    Lansing, Michigan 48912-1811
    Dermatologic Complications, Unspecified Adult Solid Tumor, Protocol Specific
    Vitamin E in Preventing Peripheral Neuropathy Caused by Chemotherapy in Patients Receiving Chemotherapy for Cancer
    Sparrow Regional Cancer Center
    Lansing, Michigan 48912-1811
    Neurotoxicity, Unspecified Adult Solid Tumor, Protocol Specific
    Citalopram in Treating Postmenopausal Women With Hot Flashes
    Sparrow Regional Cancer Center
    Lansing, Michigan 48912-1811
    Breast Cancer, Hot Flashes, Psychosocial Effects of Cancer and Its Treatment
    Methylphenidate in Treating Patients With Fatigue Caused by Cancer
    Sparrow Regional Cancer Center
    Lansing, Michigan 48912-1811
    Fatigue, Unspecified Adult Solid Tumor, Protocol Specific
    Carboplatin and ABI-007 in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery
    Sparrow Regional Cancer Center
    Lansing, Michigan 48912-1811
    Melanoma (Skin)
    Patient-Reported Outcomes in Long-Term Survivors of Colon and Rectal Cancers
    Sparrow Regional Cancer Center

    Trial Locations
    Sparrow Regional Cancer Center
    Breslin Cancer Center at Ingham Regional Medical Center
    Colorectal Cancer, Fatigue, Long-term Effects Secondary to Cancer Therapy in Adults, Pain, Psychosocial Effects of Cancer and Its Treatment
    Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
    Sparrow Hospital
    Lansing, Michigan 48912
    Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, Recurrent Adult Brain Tumor
    Fulvestrant and Bevacizumab in Treating Patients With Metastatic Breast Cancer
    Sparrow Regional Cancer Center
    Lansing, Michigan 48912-1811
    Breast Cancer
    Registration and Informed Consent Study for the Childhood Cancer Research Network
    Breslin Cancer Center at Ingham Regional Medical Center
    Lansing, Michigan 48910
    Unspecified Childhood Solid Tumor, Protocol Specific
    Mometasone Furoate in Preventing Radiation Dermatitis in Patients Undergoing Radiation Therapy to the Breast or Chest Wall for Invasive Breast Cancer or Ductal Carcinoma in Situ
    Sparrow Regional Cancer Center
    Lansing, Michigan 48912-1811
    Breast Cancer, Dermatologic Complications, Radiation Toxicity, Skin Reactions Secondary to Radiation Therapy
    Safety and Efficacy of Angiotech Vascular Wrap Paclitaxel-Eluting Mesh for Hemodialysis Vascular Access
    Thoracic And Cardiovascular Healthcare Foundation
    Lansing, Michigan 48910
    Kidney Diseases, ESRD
    cRisk-Group Classification of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
    Breslin Cancer Center at Ingham Regional Medical Center
    Lansing, Michigan 48910
    Leukemia
    Study of EC145 in Patients With Progressive Adenocarcinoma of the Lung
    Great Lakes Cancer Institute MSU
    Lansing, Michigan 48910
    Adenocarcinoma of the Lung
    A Study of Lintuzumab (SGN-33) in Combination With Low Dose Cytarabine in Patients 60+ Years With AML
    Michigan State University, Breslin Cancer Center
    Lansing, Michigan 48910
    Acute Myeloid Leukemia